Pharvaris PHVS
NASDAQ PHVS
$36.14 +0.48 (+1.35%)
As of: Sep 4, 2026 · 1:34 PM EDT

Pharvaris (PHVS) Other Non Operating Income (2020 - 2025)

Pharvaris' (PHVS) quarterly Other Non Operating Income came in at -$6.6 million in Q2 2025, down 335.69% YoY from $2.8 million in Q2 2024, and down 335.69% on a QoQ basis from $2.8 million in Q2 2024.

Analysis

Pharvaris (PHVS) Other Non Operating Income (2020 - 2025) Analysis & Trends

Pharvaris (PHVS) has 6 years of Other Non Operating Income data on file, last reported at -$6.6 million in Q2 2025.

  • Quarterly Other Non Operating Income fell 335.69% year-over-year to -$6.6 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was -$3.2 million (down 120.36% YoY) and the FY2025 annual result came in at -$11.6 million, down 235.98% from the prior year.
  • Other Non Operating Income eased to -$6.6 million in Q2 2025, from $2.8 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $12.3 million in Q2 2022 to a low of -$6.6 million in Q2 2025.
  • A 5-year average of $2.7 million and a median of $3.3 million in 2024 frame the typical range for Other Non Operating Income.
  • The widest YoY moves for Other Non Operating Income: up 20896.33% in 2021, down 13639.54% in 2021.
  • Tracing PHVS's Other Non Operating Income over 5 years: stood at $4.8 million in 2021, then jumped by 158.56% to $12.3 million in 2022, then tumbled by 94.09% to $727085.7 in 2023, then jumped by 287.56% to $2.8 million in 2024, then tumbled by 335.69% to -$6.6 million in 2025.
  • The last three Other Non Operating Income figures came in at -$6.6 million (Q2 2025), $2.8 million (Q2 2024), and $727085.7 (Q2 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn -
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn -
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn
10 Pharvaris 2.14 Bn 1.77 Bn 85,072.10
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 2.74 Mn
Jun 30, 2025 -5.55 Mn
Mar 31, 2025 -4.05 Mn
Sep 30, 2024 -3.93 Mn
Jun 30, 2024 5.08 Mn
Mar 31, 2024 628,156.10
Dec 31, 2023 -5.18 Mn
Sep 30, 2023 2.99 Mn
Mar 31, 2023 -1.60 Mn
Dec 31, 2022 11,285.07 Bn
Mar 31, 2022 3.81 Mn
Dec 31, 2021 -8.71 Mn
Sep 30, 2021 5.02 Mn
Jun 30, 2021 -2.98 Mn
Mar 31, 2021 7.02 Mn
Dec 31, 2020 203,159.04
Sep 30, 2020 -147,572.54
Jun 30, 2020 -21,688.85
Mar 31, 2020 -33,750.73